Skip to content

Vivani Medical VANI Accounts Payable

Accounts Payable at other companies

Eli Lilly logo
Eli LillyLLY
$5.03B+46.1%
Amgen logo
AmgenAMGN
$2.94B+22.0%
Altimmune logo
AltimmuneALT
$1.53M+42.1%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$67.18M+772%
Wave Life Sciences logo
Wave Life SciencesWVE
$19.06M+32.8%
Prime Medicine logo
Prime MedicinePRME
$12.33M+22.9%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's accounts payable?
Vivani Medical (VANI) reported accounts payable of $1.47M in Q1 2026.
How has Vivani Medical's accounts payable changed year-over-year?
Vivani Medical's accounts payable increased by 45.9% year-over-year, from $1M to $1.47M.
What is the long-term trend for Vivani Medical's accounts payable?
Over 5 years (2020 to 2025), Vivani Medical's accounts payable has grown at a 16.3% compound annual growth rate (CAGR), from $486K to $1.03M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.